Published on 2/15/2005 in the Prospect News Convertibles Daily.
New Issue: Goldman Sachs prices $20 million 7.4% trigger notes exchangeable for Merck
New York, Feb. 15 - The Goldman Sachs Group Inc. priced $20 million of one-year 7.4% trigger notes mandatorily exchangeable for the common stock of Merck & Co. Inc., according to a 424B3 filing with the Securities and Exchange Commission.
Issuer: | Goldman Sachs Group Inc.
|
Underlying stock: | Merck & Co. Inc.
|
Issue: | Trigger mandatory exchangeable medium-term notes
|
Amount: | $20.000 million
|
Maturity: | Feb. 17, 2006
|
Coupon: | 7.4%, payable quarterly
|
Price: | Par of $28.733
|
Payout at maturity: | 1 share of Merck stock per $28.733 principal amount, capped at $31.6063 or 110% above initial stock price of $28.733, in cash or stock at Goldman's option; if market price does not fall below threshold price, then payout has a floor of par, in cash or stock at Goldman's option
|
Threshold price: | $23.561, 82% of initial price of $28.733
|
Call: | Non-callable
|
Pricing date: | Feb. 9
|
Settlement date: | Feb. 16
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.